Related Experiment Video
Updated: Aug 7, 2026
Evaluation of Respiratory System Mechanics in Mice using the Forced Oscillation Technique
Published on: May 15, 2013
Influence of respiratory efforts on b2-agonist induced bronchodilation in mechanically ventilated COPD patients: a
P Malliotakis1, E Mouloudi, G Prinianakis
1Intensive Care Medicine Department, University Hospital of Heraklion, University of Crete, Heraklion, 71110 Crete, Greece.
Background:
Several in vitro studies have shown that at similar tidal volume (VT), bronchodilator delivery to target sites is significantly lower during controlled mechanical ventilation (CMV) than that during simulated spontaneous breathing. However, the influence of active respiratory efforts on the magnitude of b2-agonist induced bronchodilation in mechanically ventilated patients has not been examined.
Objective:
To examine the influence of controlled and assisted modes of ventilatory support on the bronchodilative effect induced by b2-agonists administered with a metered dose inhaler (MDI) and a spacer device in a homogeneous group of mechanically ventilated patients with acute exacerbation of chronic obstructive pulmonary disease (COPD).
Methods:
Prospective clinical study. Ten mechanically ventilated patients with acute exacerbation of COPD were prospectively randomized to receive 4 puffs of salbutamol (S, 100 micro g/puff) either with volume-controlled (VC) or pressure-support (PS) ventilation. On PS the pressure level was such that VT was comparable between ventilatory modes. After a 6-h washout period, patients were crossed-over to receive the drug by the alternative mode of ventilation. Static and dynamic airway pressures, minimum (R(int)) and maximum (R(rs)) inspiratory resistance, the difference between R(rs) and R(int) (DeltaR), end-inspiratory static compliance of the respiratory system (C(rs)), intrinsic positive end-expiratory pressure (PEEP(i)) and heart rate (HR) were measured before and at 15, 30, 60, 120, 180 and 240 min after S administration.
Results:
S caused a significant decrease in dynamic and static airway pressures, PEEP(i), R(int) and R(rs). These changes were not influenced by the ventilatory mode and were evident at 15, 30, 60 and 120 min after S. HR, C(rs) and DeltaR did not change after S administration.
Conclusions:
Considering the use of propofol with its presumed bronchodilative properties as a shortcoming of our study, it is concluded that the magnitude of bronchodilation induced by salbutamol delivered by an MDI and a spacer device in mechanically ventilated COPD patients is not affected by the presence or absence of active respiratory efforts.
Related Concept Videos
01:26COPD: Management Using Bronchodilators and Corticosteroids
01:19Factors Affecting Pulmonary Ventilation
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
01:24Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:23Physiological Control of Respiration
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation